Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04218409
EARLY_PHASE1

Opioid-Sparing and Pain-Reducing Properties of Syntocinon: A Dose-Effect Determination

Sponsor: University of Florida

View on ClinicalTrials.gov

Summary

Some research suggests that administration of oxytocin with oxycodone may reduce its abuse liability and improve its ability to reduce pain. In a 6-session laboratory study, the investigators will be evaluating the effects of oxycodone and oxytocin (combined and separately, across sessions) on experimentally-induced pain, subjective effects, decision-making, and activation of different neural substrates.

Key Details

Gender

All

Age Range

21 Years - 45 Years

Study Type

INTERVENTIONAL

Enrollment

45

Start Date

2021-09-02

Completion Date

2026-12-31

Last Updated

2026-01-14

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

OxyCODONE 5 mg Oral Tablet

Oral oxycodone 5 mg orally

DRUG

Oxytocin nasal spray

Intranasal oxytocin administration (48 IU)

OTHER

Placebo Oxycodone

Oxycodone 0 mg orally

OTHER

Placebo oxytocin

Intranasal placebo administration

DRUG

OxyCODONE 2.5 mg Oral Tablet

Oral oxycodone 2.5 mg orally

Locations (1)

University of Florida

Gainesville, Florida, United States